AN1 0.00% 0.7¢ anagenics limited

Midkine News 2020, page-31

  1. 551 Posts.
    lightbulb Created with Sketch. 173
    15 June 2020

    https://academic.oup.com/ndt/article/doi/10.1093/ndt/gfaa084/5857810


    Midkine and chronic kidney disease–associated multisystem organ dysfunctions

    This review summarizes the growing body of evidence supporting MK’s potential role in driving CKD-related multisystem disease, including MK’s relationship with the endothelial glycocalyx, the deranged MK levels and glycocalyx profile in CKD patients and a proposed model of MK organ interplay in CKD disease processes and highlights the importance of ongoing research into MK’s potential as a therapeutic target.

    Victoria K Campbell, Ryan P Gately, Rathika Krishnasamy, Dominic Burg, Graham R Robertson, Nicholas A Gray

 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $3.229M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $119 17.02K

Buyers (Bids)

No. Vol. Price($)
3 197856 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 280000 1
View Market Depth
Last trade - 11.44am 30/07/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.